Insider Trading Activity RTI Surgical Inc (NASDAQ:RTIX) – CEO Bought 61,693 shares of Stock

26

Insider Trading Activity For RTI Surgical Inc (NASDAQ:RTIX)

Camille Farhat , CEO of RTI Surgical Inc (NASDAQ:RTIX) reportedly Bought 61,693 shares of the company’s stock at an average price of 4.65 for a total transaction amount of $286,872.45 SEC Form

Insider Trading History For RTI Surgical Inc (NASDAQ:RTIX)

  • On 10/31/2013 Thomas F Rose, COO, bought 3,000 with an average share price of $2.97 per share and the total transaction amounting to $8,910.00. View SEC Filing
  • On 11/5/2013 Julianne Bowler, Director, bought 5,244 with an average share price of $2.89 per share and the total transaction amounting to $15,155.16. View SEC Filing
  • On 2/17/2017 Camille Farhat, CEO, bought 83,000 with an average share price of $3.44 per share and the total transaction amounting to $285,520.00. View SEC Filing
  • On 3/2/2017 Jonathon M Singer, Director, bought 10,000 with an average share price of $3.79 per share and the total transaction amounting to $37,900.00. View SEC Filing
  • On 5/2/2017 Thomas Mceachin, Director, bought 4,500 with an average share price of $4.35 per share and the total transaction amounting to $19,575.00. View SEC Filing
  • On 5/3/2017 Kevin D Brandt, EVP, bought 33,130 with an average share price of $4.52 per share and the total transaction amounting to $149,747.60. View SEC Filing
  • On 5/4/2017 Nicholas J Valeriani, Director, bought 5,500 with an average share price of $4.60 per share and the total transaction amounting to $25,300.00. View SEC Filing
  • Analyst Ratings For RTI Surgical Inc (NASDAQ:RTIX)
    These are 1 Hold Rating .
    The current consensus rating for RTI Surgical Inc (NASDAQ:RTIX) is Hold (Score: 2.00) with a consensus target price of $4.00 , a potential (15.79% downside)

    Analyst Ratings History For RTI Surgical Inc (NASDAQ:RTIX)

    • On 5/21/2015 Sidoti Initiated Coverage of rating Buy with a price target of $9.00
    • On 10/30/2015 Canaccord Genuity Downgraded rating Buy to Hold with a price target of $8.00 to $4.00
    • On 7/28/2016 Craig Hallum Downgraded rating Buy to Hold with a price target of $6.00 to $4.00

    About RTI Surgical Inc (NASDAQ:RTIX)
    RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes, and manufactures metal and synthetic implants for distribution to hospitals and surgeons. The Company distributes its implants and services in approximately 50 states and in over 45 countries across the world.

    Recent Trading Activity for RTI Surgical Inc (NASDAQ:RTIX)
    Shares of RTI Surgical Inc closed the previous trading session at 4.93 up +0.18 3.68% with 316,192 shares trading hands.

    An ad to help with our costs